Pharmaceutical Executive’s Post

Join us in Lisbon this April for the Digital Solutions User Group Meeting showcasing the latest advancements in PAT, Data Analytics and Process Monitoring. Come meet our experts to discuss BioPharma 4.0 and the latest in Digital Solutions Concept 🔬 #sartorius #biopharma4.0 #digitalsolutions #PAT #digitaltransformation

Thank you to Rob Ocel for hosting this interview with Lee Dash! They talked about the state of tech in pharmaceuticals, the importance of cross-team collaboration, & the efforts to optimize tech in an industry with so many legacy systems. Really great listen for anybody working in industries with really old legacy systems like banks, hospitals, etc. Check out the link in the comments.

Discover how technology enhances clinical trials. Advanced tools and analytics improve efficiency and accuracy, driving faster, more reliable research outcomes. Learn more with PolyCRA. #SanAntonioTX #ClinicalResearchTraining #TechInResearch

From its current state of application to benefits, case studies of its success, and more, Tom Zhang’s upcoming presentation at the Immunogenicity & Bioassay Summit will provide a thorough overview of bioanalytical automation. Interested in learning more? Schedule a meeting with our team or stop by Booth 1 to learn more about this leading innovation: https://ow.ly/f0iK50THe22

Ever wonder why some biopharma giants rapidly embrace Process Analy Technology (PAT) while others hesitate? The reason often lies not in reluctance but in the readiness of available technology. The industry recognizes PAT's promise, but the lack of commercial availability of low-cost, reliable sensors for key quality attributes is a real bottleneck. It's a paradox where desire meets practicality. But the industry is on the brink of innovation, and the benefits are too significant to ignore. Stay tuned as we explore how PAT is shaping our future! #BiopharmaInnovation #PAT #ProcessAnalyticalTechnology https://lnkd.in/g5CyEDUX

🗓️ Save the date! We’re proud to be a sponsor of this year’s European Biomanufacturing Summit, taking place from the 10th – 11th September in Berlin, Germany and hosted by Generis. The European Biomanufacturing Summit brings together over 150 #biopharma leaders in a forum exploring critical topics in quality, manufacturing, regulatory compliance and supply chain and logistics. At this year’s summit, there is a particular focus on strategies to maximize efficiency while remaining compliant to evolving regulations. We will present our IDBS PIMS and Polar solutions for efficient and compliant data management. IDBS PIMS software provides life science organizations developing and manufacturing clinical and commercial-stage therapeutics with a centralized data library, while the Polar platform offers secure and streamlined product lifecycle data management leveraging a digital data backbone. Visit us at booth # 11 or attend Ken Forman’s workshop, Speed to Market: The Power of Centralized Data and the Promise of AI, on September 10th to learn more, registration link in the comments. #datamanagement #GenerisBIOEU #BioEU24

Exciting news! Recipharm has launched ReciPredict, a cutting-edge platform that integrates statistical modeling and simulation to streamline Quality by Design (QbD) practices in drug product development, tech transfer, and manufacturing. ReciPredict is a game-changer, accelerating the progression of new drugs to the clinical stage by minimizing test cycles, thus significantly expediting the drug development timeline. This innovative platform also brings substantial cost savings by reducing API consumption and mitigates risks in technology transfers by pinpointing optimal parameters for process robustness, ensuring consistent high-quality outcomes. Curious to learn more about how ReciPredict can fast-track your product's journey to market? Dive into our informative factsheet here: https://lnkd.in/g9_6bEvm For personalized insights and to explore the full potential of ReciPredict, reach out to sharath.rangappa@recipharm.com to schedule call with our experts. #Recipharm #ReciPredict #DrugDevelopment #Innovation #QbD

Check out the revamped safety data intelligence tool OFF-X. Identify potential risks and adverse drug reactions during drug development and post-marketing. #drugsafety #toxicology

The influx of unstructured data across life sciences presents a major challenge when it comes to managing the volume of adverse events. With 90% of biopharma and medtech expecting GenAI to impact their organizations within the year, many remain of wary of the risks. However, IQVIA’s Uwe Trinks argues that we cannot disregard emerging technologies simply on account of imperfection. Read more. https://bit.ly/3UQwbo5 #GenAI

Want to revolutionize your biopharma tech strategy? Join us for a discussion with industry experts Malay Gandhi and DeAnna Zacherl. Gain actionable insights from the latest State of Tech in Biopharma Report. Download today! https://lnkd.in/efnNJgf8